Briejer MR, Bosmans JP, Van Daele P, Jurzak M, Heylen L, Leysen JE, et al. (iunie 2001). „The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound”. European Journal of Pharmacology. 423 (1): 71–83. doi:10.1016/S0014-2999(01)01087-1. PMID11438309.
Bouras EP, Camilleri M, Burton DD, Thomforde G, McKinzie S, Zinsmeister AR (februarie 2001). „Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder”. Gastroenterology. 120 (2): 354–60. doi:10.1053/gast.2001.21166. PMID11159875.
Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L (martie 2009). „Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives”. Gut. 58 (3): 357–65. doi:10.1136/gut.2008.162404. PMID18987031.
drugbank.ca
„Prucalopride”. DrugBank - Canadian Institutes of Health Research. Accesat în .
prucalopride (în engleză), Global Substance Registration System, accesat în
nih.gov
ncbi.nlm.nih.gov
Briejer MR, Bosmans JP, Van Daele P, Jurzak M, Heylen L, Leysen JE, et al. (iunie 2001). „The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound”. European Journal of Pharmacology. 423 (1): 71–83. doi:10.1016/S0014-2999(01)01087-1. PMID11438309.
Bouras EP, Camilleri M, Burton DD, Thomforde G, McKinzie S, Zinsmeister AR (februarie 2001). „Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder”. Gastroenterology. 120 (2): 354–60. doi:10.1053/gast.2001.21166. PMID11159875.
Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L (martie 2009). „Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives”. Gut. 58 (3): 357–65. doi:10.1136/gut.2008.162404. PMID18987031.